Gefei He
Impact in
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- COVID-19 Clinical Research Studies 4
- Antifungal resistance and susceptibility 3
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- Juanjuan Huang (9 shared papers)Ji Su Sun (4 shared papers)Jinhui Feng (2 shared papers)Jiyang Liu (2 shared papers)Xiaoping Chen (1 shared paper)Yanfei Li (1 shared paper)Qiang Qu (4 shared papers)Jian Qu (4 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)PLoS ONE (2 papers)BMC Medical Research Methodology (1 paper)Briefings in Bioinformatics (1 paper)International Journal of Clinical Pharmacy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Gefei He
22 papers receiving 293 citations
Peers
Comparison fields: 5 of 77
- Applied Microbiology and Biotechnology 12
- Toxicology 20
- Molecular Medicine 29
- Biological Psychiatry 13
- Infectious Diseases 87
Countries citing papers authored by Gefei He
This map shows the geographic impact of Gefei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gefei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gefei He more than expected).
Fields of papers citing papers by Gefei He
This network shows the impact of papers produced by Gefei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gefei He. The network helps show where Gefei He may publish in the future.
Co-authors
The 25 scholars most cited alongside Gefei He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 74 | |
| 2 | 2017 | 68 | |
| 3 | 2024 | 33 | |
| 4 | 2020 | 31 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 16 | |
| 7 | 2022 | 9 | |
| 8 | 2020 | 8 | |
| 9 | 2024 | 7 | |
| 10 | 2020 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2022 | 1 |
About Gefei He
Gefei He is a scholar working on Infectious Diseases, Pharmacology, Toxicology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 297 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), COVID-19 Clinical Research Studies (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Antifungal resistance and susceptibility (3 papers), Antibiotic Resistance in Bacteria (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Antibiotic Use and Resistance (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (12 citations), Toxicology (20 citations), Molecular Medicine (29 citations), Biological Psychiatry (13 citations) and Infectious Diseases (87 citations). Gefei He has collaborated with scholars based in China and United States. Frequent co-authors include Juanjuan Huang, Ji Su Sun, Jinhui Feng, Jiyang Liu, Xiaoping Chen, Yanfei Li, Qiang Qu, Jian Qu, Qiong Lu and Qing Zhu. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, BMC Medical Research Methodology, Briefings in Bioinformatics and International Journal of Clinical Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.